U.S. to work with Japan to avoid shipment of risky beef part

U.S. to work with Japan to avoid shipment of risky beef part

TOKYO, Japan - James Zumwalt, minister counselor for economic affairs at the U.S. Embassy, talks to reporters in Tokyo Jan. 20 on a bovine body part deemed a mad cow disease risk found mixed in with beef shipped to Japan.

  • Product Code
  • ILEA001112916
  • Registered date
  • 2006/1/20 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2006 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 418.17(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Senior Japan finance ministry official on exchange market

    Senior Japan finance ministry official on exchange market

    Japanese Vice Finance Minister for International Affairs Masato Kanda (far R) meets the press at the Finance Ministry building in Tokyo on July 12, 2024, after the U.S. dollar's plunge against the yen in New York overnight. Japan's top currency diplomat Kanda told reporters he would not comment on whether authorities intervened in the currency market.
      Senior Japan finance ministry official on exchange market

      Senior Japan finance ministry official on exchange market

      Japanese Vice Finance Minister for International Affairs Masato Kanda meets the press in Tokyo on July 11, 2024, after the U.S. dollar's plunge against the yen in New York the same day. Japan's top currency diplomat Kanda told reporters he would not comment on whether authorities intervened in the currency market.
        Senior Japan finance ministry official on exchange market

        Senior Japan finance ministry official on exchange market

        Japanese Vice Finance Minister for International Affairs Masato Kanda meets the press in Tokyo on July 11, 2024, after the U.S. dollar's plunge against the yen in New York the same day. Japan's top currency diplomat Kanda told reporters he would not comment on whether authorities intervened in the currency market.
          Japan Finance Minister Suzuki in Washington

          Japan Finance Minister Suzuki in Washington

          Japanese Finance Minister Shunichi Suzuki (far L) speaks to reporters after holding talks with U.S. Treasury Secretary Janet Yellen in Washington on April 17, 2024.
            Japan Finance Minister Suzuki in Washington

            Japan Finance Minister Suzuki in Washington

            Japanese Finance Minister Shunichi Suzuki speaks to reporters after holding talks with U.S. Treasury Secretary Janet Yellen in Washington on April 17, 2024.
              Japan PM, BOJ chief meeting

              Japan PM, BOJ chief meeting

              Bank of Japan Governor Kazuo Ueda (C) speaks to reporters at the premier's office in Tokyo on March 19, 2024, after holding talks with Prime Minister Fumio Kishida following the central bank's decision to end its negative interest rate policy.
                Japan PM, BOJ chief meeting

                Japan PM, BOJ chief meeting

                Bank of Japan Governor Kazuo Ueda speaks to reporters at the premier's office in Tokyo on March 19, 2024, after holding talks with Prime Minister Fumio Kishida following the central bank's decision to end its negative interest rate policy.
                  Japan's top currency diplomat Kanda

                  Japan's top currency diplomat Kanda

                  Masato Kanda, Japanese vice finance minister for international affairs, speaks to reporters at the Finance Ministry in Tokyo on Oct. 4, 2023, over the yen's volatile trading.
                    OpenAI CEO in Japan

                    OpenAI CEO in Japan

                    Sam Altman, CEO of OpenAI, the U.S. startup that developed ChatGPT, speaks to reporters after meeting with Japanese Prime Minister Fumio Kishida at his office in Tokyo on April 10, 2023.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.